Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4.

Ozer A, Bruick RK.

Cell Cycle. 2005 Sep;4(9):1153-6. Epub 2005 Sep 19. Review.

PMID:
16096374
2.

The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).

Ozer A, Wu LC, Bruick RK.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7481-6. Epub 2005 May 16.

3.

Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.

Martin F, Linden T, Katschinski DM, Oehme F, Flamme I, Mukhopadhyay CK, Eckhardt K, Tröger J, Barth S, Camenisch G, Wenger RH.

Blood. 2005 Jun 15;105(12):4613-9. Epub 2005 Mar 1.

4.

Hypoxia-inducible factor 1 (HIF-1) pathway.

Semenza GL.

Sci STKE. 2007 Oct 9;2007(407):cm8. Review.

5.

Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2.

Berchner-Pfannschmidt U, Yamac H, Trinidad B, Fandrey J.

J Biol Chem. 2007 Jan 19;282(3):1788-96. Epub 2006 Oct 23.

6.

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.

Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D, Mancini C, Lazzaretti M, Mazzera L, Ravanetti L, Bonomini S, Ferrari L, Miranda C, Ladetto M, Neri TM, Neri A, Greco A, Mangoni M, Bonati A, Rizzoli V, Giuliani N.

Blood. 2007 Dec 15;110(13):4464-75. Epub 2007 Sep 11. Erratum in: Blood. 2008 Sep 1;112(5):2170..

7.
8.

HIF prolyl 4-hydroxylases and their potential as drug targets.

Myllyharju J.

Curr Pharm Des. 2009;15(33):3878-85. Review.

PMID:
19671043
9.

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.

Hewitson KS, Schofield CJ, Ratcliffe PJ.

Methods Enzymol. 2007;435:25-42.

PMID:
17998047
10.
11.

[The new face of factors induced by hypoxia--HIF-1 and HIF-2 and oxidative stress].

Stachurska A, Florczyk U, Józkowicz A, Dulak J, Łoboda A.

Postepy Biochem. 2010;56(2):156-64. Review. Polish.

PMID:
20873110
12.

Degradation of the hypoxia-inducible factor 1alpha: where does it happen?

Pereira T, Zheng X, Poellinger L.

Cell Cycle. 2006 Dec;5(23):2720-2. Epub 2006 Dec 1.

PMID:
17172857
13.

Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase.

Temes E, Martín-Puig S, Acosta-Iborra B, Castellanos MC, Feijoo-Cuaresma M, Olmos G, Aragonés J, Landazuri MO.

J Biol Chem. 2005 Jun 24;280(25):24238-44. Epub 2005 Apr 23.

14.

The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3).

Hopfer U, Hopfer H, Jablonski K, Stahl RA, Wolf G.

J Biol Chem. 2006 Mar 31;281(13):8645-55. Epub 2006 Jan 3.

15.

HIF-1 and p53: communication of transcription factors under hypoxia.

Schmid T, Zhou J, Brüne B.

J Cell Mol Med. 2004 Oct-Dec;8(4):423-31. Review.

16.

Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype.

Irwin R, LaPres JJ, Kinser S, McCabe LR.

J Cell Biochem. 2007 Feb 15;100(3):762-72.

PMID:
17031858
17.

Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.

Bernhardt WM, Câmpean V, Kany S, Jürgensen JS, Weidemann A, Warnecke C, Arend M, Klaus S, Günzler V, Amann K, Willam C, Wiesener MS, Eckardt KU.

J Am Soc Nephrol. 2006 Jul;17(7):1970-8. Epub 2006 Jun 8.

18.

n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems.

Kimura M, Takabuchi S, Tanaka T, Murata M, Nishi K, Oda S, Oda T, Kanai M, Fukuda K, Kizaka-Kondoh S, Adachi T, Takabayashi A, Semenza GL, Hirota K.

Biochem J. 2008 Apr 1;411(1):97-105.

PMID:
18047470
20.

Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.

Elser M, Borsig L, Hassa PO, Erener S, Messner S, Valovka T, Keller S, Gassmann M, Hottiger MO.

Mol Cancer Res. 2008 Feb;6(2):282-90. doi: 10.1158/1541-7786.MCR-07-0377.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk